![]() |
Olga Potapova Olga Potapova has extensive scientific management expertise in translational oncology and diagnostics. She worked on development of targeted therapies (SUTENT) and human prenatal diagnostic tests (CF); coordinated major international collaboration projects with an emphasis on RTK signal transduction research, human biospecimen procurement, preclinical and early clinical development. Since 2010, Dr. Potapova is a Principal Investigator for The Cancer Genome Atlas (TCGA) and CPTAC programs (National Cancer Institute, NIH) |